In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant

Antiviral Research

Volumn 90, Issue 3, 2011, Pages 99-107

  Delogu, Ilenia ^a   Pastorino, Boris ^a   Baronti, Cécile ^a   Nougairède, Antoine ^a   Bonnet, Emilie ^a   de Lamballerie, Xavier ^a  

^a Aix Marseille University IRD 190 Inserm 1207   (France)

Author keywords

Alphavirus; Antiviral; Arbidol; Arbidol resistance; Chikungunya virus; Mutant

Indexed keywords

ARBIDOL; GLYCOPROTEIN E2;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ARTICLE; CELL IMMORTALIZATION; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VERO CELL; VIRUS REPLICATION;

ALPHAVIRUS INFECTIONS; ANTIVIRAL AGENTS; CELL LINE; CHIKUNGUNYA VIRUS; DRUG RESISTANCE, VIRAL; HUMANS; INDOLES; MUTATION; VIRUS REPLICATION;

ALPHAVIRUS; CHIKUNGUNYA VIRUS;

EID: 79953805715     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.03.182     Document Type: Article

References (38)

1. Anisimova, O.S.F., Frolova, L.V., Chistyakov, V.V., Ermachenkov, I.A., Golovanova, I.V.Z., S.A., Pleshkova, A.P., Yadrovskaya, V.A., Sheinker, Y.N., 1995. Study of metabolism of the antiviral drug arbidol by mass spectrometry, thin-layer and high-performance liquid chromatography. Pharm. Chem. J. 29, 78-82.
2. Arankalle V.A., Shrivastava S., Cherian S., Gunjikar R.S., Walimbe A.M., Jadhav S.M., Sudeep A.B., Mishra A.C. Genetic divergence of Chikungunya viruses in India (1963-2006) with special reference to the 2005-2006 explosive epidemic. J Gen Virol 2007, 88:1967-1976.
3. Borgherini G., Poubeau P., Jossaume A., Gouix A., Cotte L., Michault A., Arvin-Berod C., Paganin F. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin. Infect. Dis. 2008, 47:469-475.
4. Boriskin Y.S., Leneva I.A., Pecheur E.I., Polyak S.J. Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. Curr. Med. Chem. 2008, 15:997-1005.
5. Briolant S., Garin D., Scaramozzino N., Jouan A., Crance J.M. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res. 2004, 61:111-117.
6. Brooks M.J., Sasadeusz J.J., Tannock G.A. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?. Curr. Opin. Pulm. Med. 2004, 10:197-203.
7. Chevillon C., Briant L., Renaud F., Devaux C. The Chikungunya threat: an ecological and evolutionary perspective. Trends Microbiol. 2008, 16:80-88.
8. Clarke D.H., Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am. J. Trop. Med. Hyg. 1958, 7:561-573.
9. Couderc T., Chretien F., Schilte C., Disson O., Brigitte M., Guivel-Benhassine F., Touret Y., Barau G., Cayet N., Schuffenecker I., Despres P., Arenzana-Seisdedos F., Michault A., Albert M.L., Lecuit M. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 2008, 4:e29.
10. Couderc T., Khandoudi N., Grandadam M., Visse C., Gangneux N., Bagot S., Prost J.F., Lecuit M. Prophylaxis and therapy for Chikungunya virus infection. J. Infect. Dis. 2009, 200:516-523.
11. de Lamballerie X., Boisson V., Reynier J.C., Enault S., Charrel R.N., Flahault A., Roques P., Le Grand R. On chikungunya acute infection and chloroquine treatment. Vector Borne Zoonotic Dis. 2008, 8:837-839.
12. de Lamballerie X., Ninove L., Charrel R.N. Antiviral treatment of chikungunya virus infection. Infect. Disord. Drug Targets 2009, 9:101-104.
13. Deng H.Y., Luo F., Shi L.Q., Zhong Q., Liu Y.J., Yang Z.Q. Efficacy of arbidol on lethal hantaan virus infections in suckling mice and in vitro. Acta Pharmacol. Sin. 2009, 30:1015-1024.
14. Economopoulou A., Dominguez M., Helynck B., Sissoko D., Wichmann O., Quenel P., Germonneau P., Quatresous I. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Reunion. Epidemiol. Infect. 2009, 137:534-541.
15. Kielian M. Structural biology: an alphavirus puzzle solved. Nature 2010, 468:645-646.
16. Lemant J., Boisson V., Winer A., Thibault L., Andre H., Tixier F., Lemercier M., Antok E., Cresta M.P., Grivard P., Besnard M., Rollot O., Favier F., Huerre M., Campinos J.L., Michault A. Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006. Crit. Care Med. 2008, 36:2536-2541.
17. Leneva I.A., Russell R.J., Boriskin Y.S., Hay A.J. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. Antiviral Res. 2009, 81:132-140.
18. Li L., Jose J., Xiang Y., Kuhn R.J., Rossmann M.G. Structural changes of envelope proteins during alphavirus fusion. Nature 2010, 468:705-708.
19. Liu M.Y., Wang S., Yao W.F., Wu H.Z., Meng S.N., Wei M.J. Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers. Clin. Ther. 2009, 31:784-792.
20. Michault A., Staikowsky F. Chikungunya: first steps toward specific treatment and prophylaxis. J. Infect. Dis. 2009, 200:489-491.
21. Panisheva E.K.M., Mikerova N.I., Nikolaeva I.S., Fomina A.N., Cherkasova A.A., Golovanova E.A., Krylova L.Y. Pharm. Chem. J. 1988, 21:1455.
22. Parola P., de Lamballerie X., Jourdan J., Rovery C., Vaillant V., Minodier P., Brouqui P., Flahault A., Raoult D., Charrel R.N. Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg. Infect. Dis. 2006, 12:1493-1499.
23. Pastorino B., Bessaud M., Grandadam M., Murri S., Tolou H.J., Peyrefitte C.N. Development of a TaqMan RT-PCR assay without RNA extraction step for the detection and quantification of African Chikungunya viruses. J. Virol. Meth. 2005, 124:65-71.
24. Pecheur E.I., Lavillette D., Alcaras F., Molle J., Boriskin Y.S., Roberts M., Cosset F.L., Polyak S.J. Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol. Biochemistry 2007, 46:6050-6059.
25. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hygiene 1938, 27:493-497.
26. Repetto G., del Peso A., Zurita J.L. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat. Protoc. 2008, 3:1125-1131.
27. Rezza G., Nicoletti L., Angelini R., Romi R., Finarelli A.C., Panning M., Cordioli P., Fortuna C., Boros S., Magurano F., Silvi G., Angelini P., Dottori M., Ciufolini M.G., Majori G.C., Cassone A. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007, 370:1840-1846.
28. Robinson M.C. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans. R. Soc. Trop. Med. Hyg. 1955, 49:28-32.
29. Santhosh S.R., Dash P.K., Parida M.M., Khan M., Tiwari M., Lakshmana Rao P.V. Comparative full genome analysis revealed E1: A226V shift in 2007 Indian Chikungunya virus isolates. Virus Res. 2008, 135:36-41.
30. Schuffenecker I., Iteman I., Michault A., Murri S., Frangeul L., Vaney M.C., Lavenir R., Pardigon N., Reynes J.M., Pettinelli F., Biscornet L., Diancourt L., Michel S., Duquerroy S., Guigon G., Frenkiel M.P., Brehin A.C., Cubito N., Despres P., Kunst F., Rey F.A., Zeller H., Brisse S. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006, 3:e263.
31. Shi L., Xiong H., He J., Deng H., Li Q., Zhong Q., Hou W., Cheng L., Xiao H., Yang Z. Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo. Arch Virol. 2007, 152:1447-1455.
32. Sourisseau M., Schilte C., Casartelli N., Trouillet C., Guivel-Benhassine F., Rudnicka D., Sol-Foulon N., Le Roux K., Prevost M.C., Fsihi H., Frenkiel M.P., Blanchet F., Afonso P.V., Ceccaldi P.E., Ozden S., Gessain A., Schuffenecker I., Verhasselt B., Zamborlini A., Saib A., Rey F.A., Arenzana-Seisdedos F., Despres P., Michault A., Albert M.L., Schwartz O. Characterization of reemerging chikungunya virus. PLoS Pathog. 2007, 3:e89.
33. Teissier E., Penin F., Pecheur E.I. Targeting cell entry of enveloped viruses as an antiviral strategy. Molecules 2011, 16:221-250.
34. Thiboutot M.M., Kannan S., Kawalekar O.U., Shedlock D.J., Khan A.S., Sarangan G., Srikanth P., Weiner D.B., Muthumani K. Chikungunya: a potentially emerging epidemic?. PLoS Negl. Trop. Dis. 2010, 4:e623.
35. Tsetsarkin K., Higgs S., McGee C.E., de Lamballerie X., Charrel R.N., Vanlandingham D.L. Infectious clones of Chikungunya virus (La Reunion isolate) for vector competence studies. Vector Borne Zoonotic Dis. 2006, 6:325-337.
36. Vanlandingham D.L., Tsetsarkin K., Hong C., Klingler K., McElroy K.L., Lehane M.J., Higgs S. Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosquitoes. Insect Biochem. Mol. Biol. 2005, 35:1162-1170.
37. Villalain J. Membranotropic effects of arbidol, a broad anti-viral molecule, on phospholipid model membranes. J. Phys. Chem. B 2010, 114:8544-8554.
38. Voss J.E., Vaney M.C., Duquerroy S., Vonrhein C., Girard-Blanc C., Crublet E., Thompson A., Bricogne G., Rey F.A. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 2010, 468:709-712.